Godrej Agrovet Reports Strong Q1 FY26 Performance with 20% Revenue Growth in Astec LifeSciences
Godrej Agrovet Limited has announced its financial results for the first quarter ended June 30, 2025. The company reported a significant growth in revenues, profitability, and operational efficiencies. The growth in profitability was mainly driven by robust volumes and improved operational efficiencies in the Vegetable Oils business. The Animal Feed business, despite healthy volume growth, had flat segment revenue due to lower realizations. The Dairy business was impacted by early rains and higher milk procurement prices. The Poultry & Processed foods business saw a decline in revenues due to lower volumes and muted realizations in the live bird category. Astec LifeSciences reported a growth in revenue of 31% on account of higher volumes in both Enterprise & CDMO categories.
Key Highlights
- Godrej Agrovet reported a strong financial performance for Q1 FY26 with a 20% Y-o-Y growth in revenues.
- The Vegetable Oils business saw significant improvement in segment revenue and margins.
- The Animal Feed business had a volume growth across all key categories but flat segment revenue due to lower realizations.
- The Dairy business was impacted by early rains and higher milk procurement prices.
- Astec LifeSciences reported a 31% growth in revenue due to higher volumes in both Enterprise & CDMO categories.